Literature DB >> 12593729

Congenital isolated central hypothyroidism caused by a "hot spot" mutation in the thyrotropin-beta gene.

Michael T McDermott1, Bryan R Haugen, Jennifer N Black, William M Wood, David F Gordon, E Chester Ridgway.   

Abstract

Two adult siblings presented to our practice with a known history of congenital central isolated hypothyroidism. Their growth, development, and general health had been normal. Although the disorder was known to result from thyrotropin (TSH) deficiency, providers in the past had made multiple adjustments in their levothyroxine replacement doses in attempts to normalize serum TSH levels. This suggests a need for better education of providers who care for patients with central hypothyroidism. We performed DNA sequencing of the TSHbeta gene and identified a homozygous single base deletion in codon 105, on exon 3, resulting in a frameshift and a premature termination signal at codon 114. This same mutation (C105FS114X) has been previously reported in South America and Europe and appears to be the most common genetic mutation associated with congenital isolated TSH deficiency. The identification of this mutation for the first time in the United States suggests that this disorder, now described in patients from countries on multiple continents, is more common than previously appreciated and may be a mutational "hot spot."

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12593729     DOI: 10.1089/105072502321085252

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  9 in total

Review 1.  Central hypothyroidism - a neglected thyroid disorder.

Authors:  Paolo Beck-Peccoz; Giulia Rodari; Claudia Giavoli; Andrea Lania
Journal:  Nat Rev Endocrinol       Date:  2017-05-26       Impact factor: 43.330

Review 2.  Minireview: Insights Into the Structural and Molecular Consequences of the TSH-β Mutation C105Vfs114X.

Authors:  Gunnar Kleinau; Laura Kalveram; Josef Köhrle; Mariusz Szkudlinski; Lutz Schomburg; Heike Biebermann; Annette Grüters-Kieslich
Journal:  Mol Endocrinol       Date:  2016-07-07

3.  A TSHβ Variant with Impaired Immunoreactivity but Intact Biological Activity and Its Clinical Implications.

Authors:  Theodora Pappa; Jesper Johannesen; Neal Scherberg; Maricel Torrent; Alexandra Dumitrescu; Samuel Refetoff
Journal:  Thyroid       Date:  2015-06-15       Impact factor: 6.568

4.  Central hypothyroidism.

Authors:  Vishal Gupta; Marilyn Lee
Journal:  Indian J Endocrinol Metab       Date:  2011-07

5.  The Pathogenic TSH β-subunit Variant C105Vfs114X Causes a Modified Signaling Profile at TSHR.

Authors:  Laura Kalveram; Gunnar Kleinau; Kamila Szymańska; Patrick Scheerer; Adolfo Rivero-Müller; Annette Grüters-Kieslich; Heike Biebermann
Journal:  Int J Mol Sci       Date:  2019-11-07       Impact factor: 5.923

6.  A RECURRENT MUTATION IN TSHB GENE UNDERLYING CENTRAL CONGENITAL HYPOTHYROIDISM UNDETECTABLE IN NEONATAL SCREENING.

Authors:  Maria de Fátima Borges; Horacio Mario Domené; Paula Alejandra Scaglia; Beatriz Hallal Jorge Lara; Heloísa Marcelina da Cunha Palhares; Andréia Vasconcelos Aguiar Santos; Amanda Lacerda Ferreira Gonçalves; Marília Matos Oliveira; Alessandra Bernadete Trovó de Marqui
Journal:  Rev Paul Pediatr       Date:  2019-06-03

7.  TSHB R75G is a founder variant and prevalent cause of low or undetectable TSH in Indian Jews.

Authors:  David Shaki; Marina Eskin-Schwartz; Noam Hadar; Emily Bosin; Lior Carmon; Samuel Refetoff; Eli Hershkovitz; Ohad S Birk; Alon Haim
Journal:  Eur Thyroid J       Date:  2022-01-07

Review 8.  Recent advances in central congenital hypothyroidism.

Authors:  Nadia Schoenmakers; Kyriaki S Alatzoglou; V Krishna Chatterjee; Mehul T Dattani
Journal:  J Endocrinol       Date:  2015-09-28       Impact factor: 4.286

9.  Molecular spectrum of TSHβ subunit gene defects in central hypothyroidism in the UK and Ireland.

Authors:  A K Nicholas; S Jaleel; G Lyons; E Schoenmakers; M T Dattani; E Crowne; B Bernhard; J Kirk; E F Roche; V K Chatterjee; N Schoenmakers
Journal:  Clin Endocrinol (Oxf)       Date:  2016-08-04       Impact factor: 3.478

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.